US7589180B2
(en)
|
2001-05-11 |
2009-09-15 |
Abbott Laboratories Inc. |
Specific binding proteins and uses thereof
|
US20110313230A1
(en)
|
2001-05-11 |
2011-12-22 |
Terrance Grant Johns |
Specific binding proteins and uses thereof
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
MXPA03011094A
(es)
*
|
2001-05-31 |
2004-12-06 |
Medarex Inc |
Citotoxinas, profarmacos, ligadores, y estabilizadores utiles para ello.
|
US6756397B2
(en)
*
|
2002-04-05 |
2004-06-29 |
Immunogen, Inc. |
Prodrugs of CC-1065 analogs
|
KR101424624B1
(ko)
*
|
2003-05-14 |
2014-07-31 |
이뮤노젠 아이엔씨 |
약물 콘쥬게이트 조성물
|
JP4991532B2
(ja)
*
|
2004-07-02 |
2012-08-01 |
ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ |
アルファヘリックス模倣体
|
EP1789091B1
(en)
*
|
2004-08-26 |
2010-08-25 |
Piramal Life Sciences Limited |
Prodrugs containing novel bio-cleavable linkers
|
CA2486285C
(en)
*
|
2004-08-30 |
2017-03-07 |
Viktor S. Goldmakher |
Immunoconjugates targeting syndecan-1 expressing cells and use thereof
|
US20110166319A1
(en)
*
|
2005-02-11 |
2011-07-07 |
Immunogen, Inc. |
Process for preparing purified drug conjugates
|
EP1853322B1
(en)
*
|
2005-02-11 |
2014-06-25 |
ImmunoGen, Inc. |
Process for preparing maytansinoid antibody conjugates
|
US7714016B2
(en)
*
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
KR101566393B1
(ko)
*
|
2005-08-03 |
2015-11-05 |
이뮤노젠 아이엔씨 |
면역접합체 제형
|
AU2006283726C1
(en)
*
|
2005-08-24 |
2015-05-07 |
Immunogen, Inc. |
Process for preparing maytansinoid antibody conjugates
|
WO2007038637A2
(en)
*
|
2005-09-26 |
2007-04-05 |
Medarex, Inc. |
Human monoclonal antibodies to cd70
|
JP5290756B2
(ja)
*
|
2005-09-26 |
2013-09-18 |
メダレックス インコーポレイテッド |
抗体−薬剤コンジュゲート及びその使用
|
US7847105B2
(en)
*
|
2005-10-26 |
2010-12-07 |
Medarex, Inc. |
Methods and compounds for preparing CC-1065 analogs
|
CA2629147A1
(en)
*
|
2005-11-17 |
2007-05-31 |
Millennium Pharmaceuticals, Inc. |
Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin
|
EP1806365A1
(en)
|
2006-01-05 |
2007-07-11 |
Boehringer Ingelheim International GmbH |
Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
|
ATE527262T1
(de)
|
2006-01-25 |
2011-10-15 |
Sanofi Sa |
Neue tomaymycin derivate enhaltende zytotoxische mittel
|
EP1832577A1
(en)
*
|
2006-03-07 |
2007-09-12 |
Sanofi-Aventis |
Improved prodrugs of CC-1065 analogs
|
ES2673822T3
(es)
*
|
2006-07-18 |
2018-06-25 |
Sanofi |
Anticuerpo antagonista contra EphA2 para el tratamiento de cáncer
|
EP1914242A1
(en)
*
|
2006-10-19 |
2008-04-23 |
Sanofi-Aventis |
Novel anti-CD38 antibodies for the treatment of cancer
|
MX2009006277A
(es)
*
|
2006-12-14 |
2009-07-24 |
Medarex Inc |
Anticuerpos humanos que se enlazan a cd70 y usos de los mismos.
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
Medarex Llc |
化學鏈接劑與可裂解基質以及其之綴合物
|
US9090693B2
(en)
|
2007-01-25 |
2015-07-28 |
Dana-Farber Cancer Institute |
Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
|
KR20090122439A
(ko)
|
2007-02-21 |
2009-11-30 |
메다렉스, 인코포레이티드 |
단일 아미노산을 갖는 화학적 링커 및 이의 접합체
|
JP5618549B2
(ja)
|
2007-03-15 |
2014-11-05 |
ルードヴィッヒ インスティテュート フォー キャンサーリサーチ リミテッド |
Egfr抗体及びsrc阻害剤を用いる治療方法及び関連製剤
|
PE20090309A1
(es)
*
|
2007-06-04 |
2009-04-18 |
Wyeth Corp |
Conjugado portador-caliqueamicina y un metodo de deteccion de caliqueamicina
|
ES2435779T3
(es)
*
|
2007-07-19 |
2013-12-23 |
Sanofi |
Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico
|
US9901567B2
(en)
|
2007-08-01 |
2018-02-27 |
Syntarga B.V. |
Substituted CC-1065 analogs and their conjugates
|
PE20140196A1
(es)
|
2007-08-09 |
2014-03-19 |
Boehringer Ingelheim Int |
Anticuerpos anti-cd37
|
JP5532486B2
(ja)
|
2007-08-14 |
2014-06-25 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
Egf受容体を標的とするモノクローナル抗体175ならびにその誘導体および用途
|
EP2227087B1
(en)
*
|
2007-11-13 |
2013-10-09 |
The Scripps Research Institute |
Cbi derivatives subject to reductive activation
|
JP5817034B2
(ja)
*
|
2007-12-26 |
2015-11-18 |
バイオテスト・アクチエンゲゼルシヤフト |
Cd138を標的とする免疫複合体及びその使用
|
JP5990365B2
(ja)
|
2007-12-26 |
2016-09-14 |
バイオテスト・アクチエンゲゼルシヤフト |
Cd138を標的とする剤及びその使用
|
WO2009080831A1
(en)
*
|
2007-12-26 |
2009-07-02 |
Biotest Ag |
Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates
|
MX2010007101A
(es)
*
|
2007-12-26 |
2011-07-01 |
Biotest Ag |
Metodos y agentes para mejorar el reconocimiento de celulas de tumor que expresan cd138.
|
KR20220035504A
(ko)
|
2008-04-30 |
2022-03-22 |
이뮤노젠 아이엔씨 |
가교제 및 그 용도
|
HUE035798T2
(en)
*
|
2008-11-03 |
2018-05-28 |
Syntarga Bv |
CC-1065 analogues and conjugates
|
IL271761B
(en)
|
2009-02-05 |
2022-09-01 |
Immunogen Inc |
(12as)-8-methoxy-9-benzyloxy-11,12,12a,13-tetrahydro-6h-indolo[2,1-c][1,4]benzodiazepine-6-one, 4-benzyloxy-5-methoxy -2-nitrobenzoic acid and a process for their preparation
|
US9238878B2
(en)
|
2009-02-17 |
2016-01-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
SG10201810743WA
(en)
|
2009-06-03 |
2018-12-28 |
Immunogen Inc |
Conjugation methods
|
US20110076232A1
(en)
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
TW201116297A
(en)
|
2009-10-02 |
2011-05-16 |
Sanofi Aventis |
Antibodies that specifically bind to the EphA2 receptor
|
EP2486023A4
(en)
|
2009-10-06 |
2014-05-07 |
Immunogen Inc |
EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
|
US8330262B2
(en)
*
|
2010-02-02 |
2012-12-11 |
International Business Machines Corporation |
Processes for enhanced 3D integration and structures generated using the same
|
TW201129384A
(en)
|
2010-02-10 |
2011-09-01 |
Immunogen Inc |
CD20 antibodies and uses thereof
|
HUE030846T2
(en)
|
2010-04-21 |
2017-06-28 |
Syntarga Bv |
Conjugates of CC-1065 analogues and bifunctional linkers
|
CN103260406B
(zh)
|
2010-12-09 |
2016-10-19 |
伊缪诺金公司 |
制备带电荷交联剂的方法
|
CN103415621A
(zh)
|
2011-01-14 |
2013-11-27 |
雷德伍德生物科技股份有限公司 |
醛标记免疫球蛋白多肽及其使用方法
|
US9534000B2
(en)
|
2011-02-15 |
2017-01-03 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives and methods of preparation
|
SI2691155T1
(sl)
|
2011-03-29 |
2019-03-29 |
Immunogen, Inc. |
Priprava majtanzinoidnih konjugatov protiteles v postopku z enim korakom
|
SG193997A1
(en)
|
2011-03-29 |
2013-11-29 |
Immunogen Inc |
Process for manufacturing conjugates of improved homogeneity
|
US8852599B2
(en)
*
|
2011-05-26 |
2014-10-07 |
Bristol-Myers Squibb Company |
Immunoconjugates, compositions for making them, and methods of making and use
|
JP6049613B2
(ja)
*
|
2011-06-06 |
2016-12-21 |
inQs株式会社 |
複合ガラス板
|
EP3228325A1
(en)
|
2011-06-10 |
2017-10-11 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
CA2836927A1
(en)
|
2011-06-21 |
2012-12-27 |
Immunogen, Inc. |
Novel maytansinoid derivatives with peptide linker and conjugates thereof
|
MX358680B
(es)
|
2011-12-08 |
2018-08-31 |
Biotest Ag |
Usos de inmunoconjugados dirigidos a cd138.
|
RU2632206C2
(ru)
*
|
2012-04-05 |
2017-10-03 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Новые алкилирующие средства
|
JP6251236B2
(ja)
*
|
2012-04-05 |
2017-12-20 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
癌を治療するための官能性チエノ−インドール誘導体
|
WO2013160396A1
(en)
|
2012-04-26 |
2013-10-31 |
Boehringer Ingelheim International Gmbh |
Combination of cd37 antibodies with bendamustine
|
EP2849784A1
(en)
|
2012-05-16 |
2015-03-25 |
Boehringer Ingelheim International GmbH |
Combination of cd37 antibodies with ice (ifosfamide, carboplatin, etoposide)
|
JP2015517512A
(ja)
|
2012-05-16 |
2015-06-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cd37抗体の更なる薬剤との併用
|
SG10201702737TA
(en)
|
2012-10-04 |
2017-05-30 |
Immunogen Inc |
Use of a pvdf membrane to purify cell-binding agent cytotoxic agent conjugates
|
AU2012395148B2
(en)
|
2012-11-24 |
2016-10-27 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
US10226535B2
(en)
|
2012-12-10 |
2019-03-12 |
Mersana Therapeutics, Inc. |
Auristatin compounds and conjugates thereof
|
CA2892863C
(en)
|
2012-12-10 |
2022-03-15 |
Mersana Therapeutics, Inc. |
Polymeric scaffold based on phf for targeted drug delivery
|
WO2014093640A1
(en)
|
2012-12-12 |
2014-06-19 |
Mersana Therapeutics,Inc. |
Hydroxy-polmer-drug-protein conjugates
|
WO2015044003A1
(en)
*
|
2013-09-25 |
2015-04-02 |
Nerviano Medical Sciences S.R.L. |
THIENO[2,3-e]INDOLE DERIVATIVES AS NEW ANTITUMOR AGENTS
|
JP6427564B2
(ja)
|
2013-10-11 |
2018-11-21 |
アサナ・バイオサイエンシズ,リミテッド・ライアビリティ・カンパニー |
タンパク質−ポリマー−薬物共役体
|
EP3054991B1
(en)
|
2013-10-11 |
2019-04-03 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
AU2015205574B2
(en)
|
2014-01-10 |
2019-08-15 |
Byondis B.V. |
Method for purifying Cys-linked antibody-drug conjugates
|
CA2935430C
(en)
|
2014-01-10 |
2018-09-18 |
Synthon Biopharmaceuticals B.V. |
Duocarmycin adcs for use in treatment of endometrial cancer
|
CA2935433C
(en)
|
2014-01-10 |
2019-04-02 |
Synthon Biopharmaceuticals B.V. |
Duocarmycin anti-her2 antibody drug conjucates with activity against her2 expressing malignancies
|
US9943606B2
(en)
|
2014-01-15 |
2018-04-17 |
Rutgers, The State University Of New Jersey |
Dendritic polypeptide-based nanocarriers for the delivery of therapeutic agents
|
ES2960619T3
(es)
|
2014-02-28 |
2024-03-05 |
Hangzhou Dac Biotech Co Ltd |
Enlazadores cargados y sus usos para la conjugación
|
PL3189056T3
(pl)
|
2014-09-03 |
2020-11-02 |
Immunogen, Inc. |
Cytotoksyczne pochodne benzodiazepinowe
|
JP2017527562A
(ja)
|
2014-09-03 |
2017-09-21 |
イミュノジェン・インコーポレーテッド |
細胞毒性ベンゾジアゼピン誘導体
|
SG10202008302XA
(en)
|
2014-12-04 |
2020-10-29 |
Celgene Corp |
Biomolecule conjugates
|
SI3313845T1
(sl)
|
2015-06-29 |
2021-01-29 |
Immunogen, Inc. |
Konjugati spremenjenih protiteles cisteina
|
NZ739830A
(en)
|
2015-07-12 |
2021-12-24 |
Hangzhou Dac Biotech Co Ltd |
Bridge linkers for conjugation of cell-binding molecules
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
KR102660070B1
(ko)
|
2015-07-21 |
2024-04-24 |
이뮤노젠 아이엔씨 |
세포독성 벤조다이아제핀 유도체의 제조 방법
|
WO2017025458A1
(en)
|
2015-08-07 |
2017-02-16 |
Gamamabs Pharma |
Antibodies, antibody drug conjugates and methods of use
|
JP2019501139A
(ja)
|
2015-11-25 |
2019-01-17 |
イミュノジェン・インコーポレーテッド |
医薬製剤及びその使用
|
JP2019515677A
(ja)
|
2016-04-26 |
2019-06-13 |
アール.ピー.シェーラー テクノロジーズ エルエルシー |
抗体複合体ならびにそれを作製および使用する方法
|
WO2017194568A1
(en)
|
2016-05-11 |
2017-11-16 |
Sanofi |
Treatment regimen using anti-muc1 maytansinoid immunoconjugate antibody for the treatment of tumors
|
EP3474901A1
(en)
|
2016-06-27 |
2019-05-01 |
Tagworks Pharmaceuticals B.V. |
Cleavable tetrazine used in bio-orthogonal drug activation
|
CN109641911B
(zh)
|
2016-08-19 |
2023-02-21 |
百时美施贵宝公司 |
seco-环丙吡咯并吲哚化合物和其抗体-药物缀合物以及制备和使用方法
|
US20210308277A1
(en)
|
2016-11-14 |
2021-10-07 |
Hangzhou Dac Biotech Co., Ltd. |
Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers
|
US10287256B2
(en)
|
2016-11-23 |
2019-05-14 |
Immunogen, Inc. |
Selective sulfonation of benzodiazepine derivatives
|
US11135307B2
(en)
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
CN110366431B
(zh)
|
2017-02-28 |
2023-07-18 |
伊缪诺金公司 |
具有自分解肽接头的类美登素衍生物和其缀合物
|
TW201839001A
(zh)
|
2017-04-20 |
2018-11-01 |
美商伊繆諾金公司 |
細胞毒性苯并二氮平衍生物及其綴合物
|
CN111315414A
(zh)
|
2017-06-22 |
2020-06-19 |
梅尔莎纳医疗公司 |
产生载药聚合物支架和蛋白-聚合物-药物缀合物的方法
|
TWI827575B
(zh)
|
2017-12-28 |
2024-01-01 |
美商伊繆諾金公司 |
苯二氮平衍生物
|
EP3787691A1
(en)
|
2018-05-04 |
2021-03-10 |
Tagworks Pharmaceuticals B.V. |
Tetrazines for high click conjugation yield in vivo and high click release yield
|
WO2019212357A1
(en)
|
2018-05-04 |
2019-11-07 |
Tagworks Pharmaceuticals B.V. |
Compounds comprising a linker for increasing transcyclooctene stability
|
JP2022513400A
(ja)
|
2018-10-29 |
2022-02-07 |
メルサナ セラピューティクス インコーポレイテッド |
ペプチド含有リンカーを有するシステイン操作抗体-薬物コンジュゲート
|
MX2021011330A
(es)
|
2019-03-20 |
2021-12-10 |
Univ California |
Anticuerpos de claudina-6 y conjugados de fármacos.
|
EP3941944A4
(en)
|
2019-03-20 |
2022-11-30 |
The Regents of the University of California |
B-SPECIFIC CLAUDIN-6 ANTIBODIES
|
JP2022529583A
(ja)
|
2019-03-29 |
2022-06-23 |
イミュノジェン・インコーポレーテッド |
異常細胞増殖を阻害するまたは増殖性疾患を治療するための細胞毒性ビス-ベンゾジアゼピン誘導体及び細胞結合剤とのその複合体
|
WO2020219287A1
(en)
|
2019-04-26 |
2020-10-29 |
Immunogen, Inc. |
Camptothecin derivatives
|
JP2022537543A
(ja)
|
2019-06-17 |
2022-08-26 |
タグワークス ファーマシューティカルス ビー.ブイ. |
高速で且つ効率的なクリック放出の為の化合物
|
IL289094A
(en)
|
2019-06-17 |
2022-02-01 |
Tagworks Pharmaceuticals B V |
Tetrazines for increasing the speed and yield of the "click release" reaction
|
CA3163833A1
(en)
|
2020-01-09 |
2021-07-15 |
Timothy B. Lowinger |
Site specific antibody-drug conjugates with peptide-containing linkers
|
AU2021226341A1
(en)
|
2020-02-25 |
2022-09-29 |
Mediboston Limited |
Camptothecin derivatives and conjugates thereof
|
EP4178624A2
(en)
|
2020-07-07 |
2023-05-17 |
Bionecure Therapeutics, Inc. |
Maytansinoids as adc payloads and their use for the treatment of cancer
|
US20220378929A1
(en)
|
2021-02-25 |
2022-12-01 |
MediBoston Limted |
Anti-her2 antibody-drug conjugates and uses thereof
|
CN118339280A
(zh)
|
2021-09-06 |
2024-07-12 |
维拉克萨生物技术有限责任公司 |
用于真核生物中遗传密码子扩展的新型氨酰tRNA合成酶变体
|
EP4186529A1
(en)
|
2021-11-25 |
2023-05-31 |
Veraxa Biotech GmbH |
Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion
|
WO2023094525A1
(en)
|
2021-11-25 |
2023-06-01 |
Veraxa Biotech Gmbh |
Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion
|
CA3239713A1
(en)
|
2021-12-08 |
2023-06-15 |
Edward A. LEMKE |
Hydrophilic tetrazine-functionalized payloads for preparation of targeting conjugates
|
EP4314031B1
(en)
|
2022-02-15 |
2024-03-13 |
Tagworks Pharmaceuticals B.V. |
Masked il12 protein
|
WO2024013723A1
(en)
|
2022-07-15 |
2024-01-18 |
Pheon Therapeutics Ltd |
Antibody drug conjugates that bind cdcp1 and uses thereof
|
US20240108744A1
(en)
|
2022-07-27 |
2024-04-04 |
Mediboston Limited |
Auristatin derivatives and conjugates thereof
|
WO2024080872A1
(en)
|
2022-10-12 |
2024-04-18 |
Tagworks Pharmaceuticals B.V. |
Strained bicyclononenes
|